Mobia Medical, INC 8-K filings
Current reports — the filing a company makes when something happens that shareholders need to know about before the next quarterly report.
NASDAQ
Mobia Medical announced a robust second quarter for 2026, with revenue soaring 102% year-over-year to $13.5 million, driven by increased adoption of its Vivistim System.
NASDAQ
Mobia Medical, Inc. has expanded its Board of Directors by appointing Dr. Myriam J. Curet, a seasoned executive with extensive experience in medical technology and surgery.
NASDAQ
Mobia Medical, Inc. has expanded its Board of Directors to seven members with the appointment of Dr. Reza Zadno, who will also serve on the Compensation Committee.